Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery

Anesthesiology

Volumn 115, Issue 5, 2011, Pages 929-937

  Yoo, Young Chul ^a   Shim, Jae Kwang ^a   Kim, Jong Chan ^a   Jo, Youn Yi ^a   Lee, Jong Hoon ^a   Kwak, Young Lan ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

EPOCAIN; FERRIC HYDROXIDE SUCROSE; IRON; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG; VENOFERRUM;

ANEMIA; ARTICLE; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; FEMALE; HEART VALVE SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETICULOCYTE COUNT; RISK ASSESSMENT; SINGLE BLIND PROCEDURE; SURGICAL PATIENT;

ADULT; AGED; ANEMIA; BLOOD TRANSFUSION; ERYTHROPOIETIN; FEMALE; HEART VALVES; HUMANS; INJECTIONS; IRON; MALE; MIDDLE AGED; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; SINGLE-BLIND METHOD;

EID: 80055016788     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e318232004b     Document Type: Article

References (41)

1. Yaziciolu L, Eryilmaz S, Sirlak M, Inan MB, Aral AR, Eren NT, Kaya B, Akalin H: Recombinant human erythropoietin administration in cardiac surgery. J Thorac Cardiovasc Surg 2001; 122:741-5
2. De Santo LS, Romano G, Galdieri N, Buonocore M, Bancone C, De Simone V, Della Corte A, Nappi G: RIFLE criteria for acute kidney injury in valvular surgery. J Heart Valve Dis 2010; 19:139-47; discussion 148
3. Bucerius J, Gummert JF, Borger MA, Walther T, Doll N, Onnasch JF, Metz S, Falk V, Mohr FW: Stroke after cardiac surgery: A risk factor analysis of 16,184 consecutive adult patients. Ann Thorac Surg 2003; 75:472-8 (Pubitemid 36184491)
4. Koch CG, Li L, Van Wagoner DR, Duncan AI, Gillinov AM, Blackstone EH: Red cell transfusion is associated with an increased risk for postoperative atrial fibrillation. Ann Thorac Surg 2006; 82:1747-56 (Pubitemid 44596264)
5. Scott BH, Seifert FC, Grimson R: Blood transfusion is associated with increased resource utilisation, morbidity and mortality in cardiac surgery. Ann Card Anaesth 2008; 11:15-9
6. Surgenor SD, Kramer RS, Olmstead EM, Ross CS, Sellke FW, Likosky DS, Marrin CA, Helm RE Jr, Leavitt BJ, Morton JR, Charlesworth DC, Clough RA, Hernandez F, Frumiento C, Benak A, DioData C, O'Connor GT, Northern New England Cardiovascular Disease Study Group: The association of perioperative red blood cell transfusions and decreased long-term survival after cardiac surgery. Anesth Analg 2009; 108:1741-6
7. Kulier A, Levin J, Moser R, Rumpold-Seitlinger G, Tudor IC, Snyder-Ramos SA, Moehnle P, Mangano DT, Investigators of the Multicenter Study of Perioperative Ischemia Research Group, Ischemia Research and Education Foundation: Impact of preoperative anemia on outcome in patients undergoing coronary artery bypass graft surgery. Circulation 2007; 116:471-9 (Pubitemid 47450255)
8. Jacobs K, Shoemaker C, Rudersdorf R, Neill SD, Kaufman RJ, Mufson A, Seehra J, Jones SS, Hewick R, Fritsch EF: Isolation and characterization of genomic and cDNA clones of human erythropoietin. Nature 1985; 313:806-10 (Pubitemid 15130833)
9. Rizzo JD, Somerfield MR, Hagerty KL, Seidenfeld J, Bohlius J, Bennett CL, Cella DF, Djulbegovic B, Goode MJ, Jakubowski AA, Rarick MU, Regan DH, Lichtin AE: Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update. Blood 2008; 111:25-41
10. Kiyama H, Ohshima N, Imazeki T, Yamada T: Autologous blood donation with recombinant human erythropoietin in anemic patients. Ann Thorac Surg 1999; 68:1652-6
11. Gombotz H: Subcutaneous epoetin alfa as an adjunct to autologous blood donation before elective coronary artery bypass graft surgery. Semin Hematol 1996; 33:69-70; discussion 71-2
12. Alghamdi AA, Albanna MJ, Guru V, Brister SJ: Does the use of erythropoietin reduce the risk of exposure to allogeneic blood transfusion in cardiac surgery? A systematic review and meta-analysis. J Card Surg 2006; 21:320-6
13. Weltert L, D'Alessandro S, Nardella S, Girola F, Bellisario A, Maselli D, De Paulis R: Preoperative very short-term, highdose erythropoietin administration diminishes blood transfusion rate in off-pump coronary artery bypass: A randomized blind controlled study. J Thorac Cardiovasc Surg 2010; 139: 621-6; discussion 626-7
14. Lippi G, Franchini M, Favaloro EJ: Thrombotic complications of erythropoiesis-stimulating agents. Semin Thromb Hemost 2010; 36:537-49
15. Sowade O, Warnke H, Scigalla P, Sowade B, Franke W, Messinger D, Gross J: Avoidance of allogeneic blood transfusions by treatment with epoetin beta (recombinant human erythropoietin) in patients undergoing open-heart surgery. Blood 1997; 89:411-8 (Pubitemid 27051675)
16. Biesma DH, Van de Wiel A, Beguin Y, Kraaijenhagen RJ, Marx JJ: Post-operative erythropoiesis is limited by the inflammatory effect of surgery on iron metabolism. Eur J Clin Invest 1995; 25:383-9
17. Karkouti K, McCluskey SA, Ghannam M, Salpeter MJ, Quirt I, Yau TM: Intravenous iron and recombinant erythropoietin for the treatment of postoperative anemia. Can J Anaesth 2006; 53:11-9 (Pubitemid 43230987)
18. van Iperen CE, Kraaijenhagen RJ, Biesma DH, Beguin Y, Marx JJ, van de Wiel A: Iron metabolism and erythropoiesis after surgery. Br J Surg 1998; 85:41-5 (Pubitemid 28034109)
19. Clemens J, Spivak JL: Serum immunoreactive erythropoietin during the perioperative period. Surgery 1994; 115:510-5 (Pubitemid 24123641)
20. Na HS, Shin SY, Hwang JY, Jeon YT, Kim CS, Do SH: Effects of intravenous iron combined with low-dose recombinant human erythropoietin on transfusion requirements in irondeficient patients undergoing bilateral total knee replacement arthroplasty. Transfusion 2011; 51:118-24
21. Goodnough LT, Shander A, Spivak JL, Waters JH, Friedman AJ, Carson JL, Keating EM, Maddox T, Spence R: Detection, evaluation, and management of anemia in the elective surgical patient. Anesth Analg 2005; 101:1858-61 (Pubitemid 41720652)
22. Murphy MF, Wallington TB, Kelsey P, Boulton F, Bruce M, Cohen H, Duguid J, Knowles SM, Poole G, Williamson LM, British Committee for Standards in Haematology, Blood Transfusion Task Force: Guidelines for the clinical use of red cell transfusions. Br J Haematol 2001; 113:24-31
23. Roques F, Michel P, Goldstone AR, Nashef SA: The logistic EuroSCORE. Eur Heart J 2003; 24:881-2
24. Molitoris BA, Levin A, Warnock DG, Joannidis M, Mehta RL, Kellum JA, Ronco C, Shah S, Acute Kidney Injury Network: Improving outcomes from acute kidney injury. J Am Soc Nephrol 2007; 18:1992-4 (Pubitemid 47041061)
25. Hoste EA, Kellum JA: Acute kidney injury: Epidemiology and diagnostic criteria. Curr Opin Crit Care 2006; 12:531-7 (Pubitemid 44673427)
26. Diprose P, Herbertson MJ, O'Shaughnessy D, Deakin CD, Gill RS: Reducing allogeneic transfusion in cardiac surgery: A randomized double-blind placebo-controlled trial of antifibrinolytic therapies used in addition to intra-operative cell salvage. Br J Anaesth 2005; 94:271-8 (Pubitemid 40352845)
27. Wehlin L, Vedin J, Vaage J, Lundahl J: Activation of complement and leukocyte receptors during on-and off pump coronary artery bypass surgery. Eur J Cardiothorac Surg 2004; 25:35-42 (Pubitemid 38019056)
28. Breymann C, Zimmermann R, Huch R, Huch A: Use of recombinant human erythropoietin in combination with parenteral iron in the treatment of postpartum anaemia. Eur J Clin Invest 1996; 26:123-30 (Pubitemid 26064615)
29. Madi-Jebara SN, Sleilaty GS, Achouh PE, Yazigi AG, Haddad FA, Hayek GM, Antakly MC, Jebara VA: Postoperative intravenous iron used alone or in combination with low-dose erythropoietin is not effective for correction of anemia after cardiac surgery. J Cardiothorac Vasc Anesth 2004; 18:59-63 (Pubitemid 38240762)
30. Haljan G, Maitland A, Buchan A, Arora RC, King M, Haigh J, Culleton B, Faris P, Zygun D: The erythropoietin neuroprotective effect: Assessment in CABG surgery (TENPEAKS): A randomized, double-blind, placebo controlled, proof-of-concept clinical trial. Stroke 2009; 40:2769-75
31. Sowade B, Sowade O, Mcks J, Franke W, Warnke H: The safety of treatment with recombinant human erythropoietin in clinical use: A review of controlled studies. Int J Mol Med 1998; 1:303-14
32. Woo S, Krzyzanski W, Jusko WJ: Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after intravenous and subcutaneous administration in rats. J Pharmacol Exp Ther 2006; 319:1297-306
33. Fisher JW: Pharmacologic modulation of erythropoietin production. Annu Rev Pharmacol Toxicol 1988; 28:101-22
34. Fleming RE, Bacon BR: Orchestration of iron homeostasis. N Engl J Med 2005; 352:1741-4 (Pubitemid 40570920)
35. Jacobs P, Finch CA: Iron for erythropoiesis. Blood 1971; 37:220-30
36. Paschos N, Lykissas MG, Beris AE: The role of erythropoietin as an inhibitor of tissue ischemia. Int J Biol Sci 2008; 4:161-8 (Pubitemid 351872045)
37. Song YR, Lee T, You SJ, Chin HJ, Chae DW, Lim C, Park KH, Han S, Kim JH, Na KY: Prevention of acute kidney injury by erythropoietin in patients undergoing coronary artery bypass grafting: A pilot study. Am J Nephrol 2009; 30:253-60
38. Karkouti K, Wijeysundera DN, Yau TM, Callum JL, Cheng DC, Crowther M, Dupuis JY, Fremes SE, Kent B, Laflamme C, Lamy A, Legare JF, Mazer CD, McCluskey SA, Rubens FD, Sawchuk C, Beattie WS: Acute kidney injury after cardiac surgery: Focus on modifiable risk factors. Circulation 2009; 119:495-502
39. Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Shapiro MJ, Corwin MJ, Colton T, EPO Critical Care Trials Group: Efficacy of recombinant human erythropoietin in critically ill patients: A randomized controlled trial. JAMA 2002; 288:2827-35 (Pubitemid 35425068)
40. Kannel WB, Gordon T, Wolf PA, McNamara P: Hemoglobin and the risk of cerebral infarction: The Framingham Study. Stroke 1972; 3:409-20
41. Remuzzi G, Ingelfinger JR: Correction of anemia-payoffs and problems. N Engl J Med 2006; 355:2144-6